GET TO KNOW STEFANIA DI MARCO
Dr. Stefania Di Marco, Ph.D.
Qualified Person and Scientific Director
Author of 57 peer-reviewed publications and inventor of four patents.
12-year experience in the evaluation and review/monitoring of EU-funded research programmes: FP7, H2020 and HORIZON proposals; Eureka-Eurostars proposals; Innovation Fund Denmark Peer Review.
18-year research experience in preclinical drug discovery and development, employing molecular biology, biochemistry and X-ray crystallography for functional studies and structure-based drug design (six years at Novartis, Basel; twelve years at IRBM-Merck, Pomezia-Roma). Main research subjects have been medically relevant protein targets in several therapeutic areas, like Infectious Diseases, Anti-Thrombotics, Cardiovascular and Oncology.
Dr. Stefania Di Marco, presenting on the topic of Viral Vaccines at World Vaccine Congress 2022 in Barcelona, Spain.